• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 3 out of 29 pages
Exam (elaborations)

D 514 Exam 3 V2 | D 514 Analytical Methods of Healthcare Leaders | Actual Q&A with Rationale (D514 Exam 3) | Western Governors University

Document preview thumbnail
Preview 3 out of 29 pages

D 514 Exam 3 V2 | D 514 Analytical Methods of Healthcare Leaders | Actual Q&A with Rationale (D514 Exam 3) | Western Governors University

Content preview

D 514 Exam 3 V2 | D 514 Analytical
Methods of Healthcare Leaders | Actual
Q&A with Rationale (D514 Exam 3) |
Western Governors University
1. A healthcare administrator is reviewing a regression analysis that predicts patient wait

times based on the number of staff on duty. The R-squared value is 0.85. What is the most

accurate interpretation of this value?

A. The correlation between staff and wait time is 0.85.


B. 85% of the variation in wait times is explained by the number of staff.


C. There is an 85% probability that wait times will decrease if staff is added.


D. The model is 85% accurate in predicting every individual wait time.


Answer: B


Rationale: The coefficient of determination, or R-squared, measures the proportion of

variance in the dependent variable that is predictable from the independent variable. In

this case, an R-squared of 0.85 indicates that 85% of the variability in patient wait times

can be explained by the staffing levels. This suggests a very strong fit for the model in a

healthcare management context.


2. When using a p-chart to monitor the proportion of medication errors in a hospital unit,

what constitutes a ‘special cause’ variation?

A. A data point that falls within one standard deviation of the mean.

,B. A random fluctuation in the error rate over time.


C. The average error rate staying consistent for six months.


D. A single data point falling outside the upper or lower control limits.


Answer: D


Rationale: Special cause variation is indicated when a data point falls outside the

established control limits on an SPC chart. This suggests that a specific, non-random factor

has influenced the process and requires investigation. Unlike common cause variation,

special causes are not inherent to the process design and can often be mitigated once

identified.


3. In the context of healthcare forecasting, what is the primary disadvantage of using a simple

moving average with a large ‘n’ period?

A. It is too sensitive to recent random fluctuations in patient volume.


B. It requires complex quadratic equations to solve for the next period.


C. It cannot be used if the data set contains fewer than 100 observations.


D. It lags behind actual trends and smooths out significant cyclical changes.


Answer: D


Rationale: A larger ‘n’ in a moving average provides more smoothing but makes the

forecast less responsive to recent changes in demand. This creates a significant lag, which

can be problematic for healthcare leaders trying to respond to rapid shifts in patient

, arrivals. Consequently, this method might fail to capture important seasonal or trend-

related surges in service needs.


4. A hospital is evaluating a new diagnostic test for a rare disease. If the test has high

sensitivity but low specificity, which of the following is true?

A. There will be many false negatives.


B. The test will accurately identify most people who do not have the disease.


C. There will be many false positives.


D. The test is perfect for confirming a diagnosis after a preliminary screen.


Answer: C


Rationale: High sensitivity means the test is good at catching true cases, but low specificity

means it often misidentifies healthy individuals as having the disease. This leads to a high

rate of false positives, which can cause unnecessary anxiety and follow-up costs for

patients. In healthcare analytics, balancing these two metrics is crucial for cost-effective

population health management.


5. Which of the following describes a Type II error in the context of a clinical trial comparing a

new drug to a placebo?

A. Concluding the drug is effective when it actually is not.


B. Concluding the drug is not effective when it actually is.


C. Setting the significance level (alpha) too low at the start of the study.

Document information

Uploaded on
July 16, 2026
Number of pages
29
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$17.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
ScholarsAscend
3.7
(80)
Sold
492
Followers
39
Items
30002
Last sold
6 hours ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions